Back

A distinct serum metabolic signature outperforms C-reactive protein as a non-invasive marker for monitoring disease activity in Inflammatory Bowel Disease

2025-12-11 gastroenterology Title + abstract only
View on medRxiv
Show abstract

BackgroundAchieving deep remission, such as e.g. histo-endoscopic remission, is a key objective in inflammatory bowel disease (IBD). However, this metric depends on invasive procedures that are impractical in routine care, whereas current non-invasive blood biomarkers demonstrate only limited correlation with disease activity. ObjectiveWe used serum metabolomics to identify blood-based signatures that comprehensively assess disease activity. DesignSerum was collected from HC (n=195), UC (n=183...

Predicted journal destinations